Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216112
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2005-09-12
Brief Title:
Imatinib Mesylate in Combination With Docetaxel for Advanced Platinum-Refractory Ovarian Cancer
Sponsor:
Daniela Matei MD
Organization:
Hoosier Cancer Research Network